StockData
COSCIENS Biopharma Inc. logo

COSCIENS Biopharma Inc. (CSCIF) stock

CSCIFOTCPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 20-F on Mar 25, 2026Score 1/30
$6.49+0.00 (0.00%)

Close on Oct 19, 2026Market cap $24.10MP/E –Yield –

COSCIENS Biopharma free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

COSCIENS Biopharma's free cash flow for the twelve months ending Mar 31, 2026 was -$8.86M. For fiscal 2025 it was -$9.18M. The highest annual figure on record is $6.82M in fiscal 2018.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$9.18M–
FY2024Dec 31, 2024-$15.73M–
FY2023Dec 31, 2023-$3.30M-167.1%
FY2022Dec 31, 2022$4.93M–
FY2021Dec 31, 2021-$8.61M-226.3%
FY2018Dec 31, 2018$6.82M–
FY2017Dec 31, 2017-$22.92M–
FY2016Dec 31, 2016-$29.08M–
FY2015Dec 31, 2015-$33.87M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2026Mar 31, 2026-$2.18M–
Q4 FY2025Dec 31, 2025-$1.52M–
Q3 FY2025Sep 30, 2025-$672.00K–
Q2 FY2025Jun 30, 2025-$4.50M–
Q1 FY2025Mar 31, 2025-$2.50M–
Q4 FY2024Dec 31, 2024-$3.31M–
Q3 FY2024Sep 30, 2024-$7.91M-8514.9%
Q2 FY2024Jun 30, 2024-$1.55M–
Q1 FY2024Mar 31, 2024-$2.94M–
Q4 FY2023Dec 31, 2023-$1.67M-111.0%
Q3 FY2023Sep 30, 2023$94.00K–
Q2 FY2023Jun 30, 2023-$867.00K–
Q1 FY2023Mar 31, 2023-$4.06M–
Q4 FY2022Dec 31, 2022$15.24M–
Q3 FY2022Sep 30, 2022-$3.95M–
Q2 FY2022Jun 30, 2022-$4.89M–
Q1 FY2022Mar 31, 2022-$1.47M–
Q4 FY2021Dec 31, 2021-$2.42M–
Q3 FY2021Sep 30, 2021-$1.49M–
Q2 FY2021Jun 30, 2021-$3.64M–
Q1 FY2021Mar 31, 2021-$1.06M–

More COSCIENS Biopharma figures

See a number that looks wrong?